Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (ARCA: DRIP)

最新ニュース Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (ARCA:DRIP)

Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3X Shares

Direxion

The index is a modified equal-weighted index that is designed to measure the performance of the oil and gas exploration and production sub-industry determined based on the GICS. The fund invests at least 80% of the fund’s net assets in swap agreements, futures contracts, short positions or other financial instruments that provide inverse or short daily exposure to the index or to ETFs that track the index which provider returns consistent with the objective. It is non-diversified.

Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares

Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options history for AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) revealed 11 unusual trades.
Delving into the details, we found 9% of traders were bullish, while 90% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $454,486, and 5 were calls, valued at $292,034.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $195.0 and $210.0 for AbbVie, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for AbbVie options trades today is 559.88 with a total volume of 4,547.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for AbbVie's big money trades within a strike price range of $195.0 to $210.0 over the last 30 days.
<h3>AbbVie Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730915232_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$1.88</td>
<td>$1.89</td>
<td>$1.89</td>
<td>$207.50</td>
<td>$163.1K</td>
<td style="text-align: right;">223</td>
<td>868</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$2.11</td>
<td>$1.78</td>
<td>$2.11</td>
<td>$197.50</td>
<td>$162.2K</td>
<td style="text-align: right;">1</td>
<td>781</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$2.25</td>
<td>$1.91</td>
<td>$2.25</td>
<td>$200.00</td>
<td>$78.7K</td>
<td style="text-align: right;">269</td>
<td>245</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$11.4</td>
<td>$11.25</td>
<td>$11.4</td>
<td>$200.00</td>
<td>$67.2K</td>
<td style="text-align: right;">53</td>
<td>60</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$1.66</td>
<td>$1.59</td>
<td>$1.66</td>
<td>$197.50</td>
<td>$52.2K</td>
<td style="text-align: right;">1</td>
<td>1.3K</td>
</tr>
</tbody>
</table>

<h3>About AbbVie</h3>
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
In light of the recent options history for AbbVie, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is AbbVie Standing Right Now?</h3>
<ul>
<li>With a trading volume of 2,248,728, the price of ABBV is up by 0.19%, reaching $202.07.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 86 days from now.</li>
</ul>
<h3>Expert Opinions on AbbVie</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $217.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $231. 
&#x2A; An analyst from Citigroup persists with their Buy rating on AbbVie, maintaining a target price of $226. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on AbbVie with a target price of $215. 
&#x2A; An analyst from BMO Capital has decided to maintain their Outperform rating on AbbVie, which currently sits at a price target of $220. 
&#x2A; An analyst from UBS persists with their Neutral rating on AbbVie, maintaining a target price of $195. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

ABBV

What the Options Market Tells Us About AbbVie

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Wednesday.
The Dow traded up 3.17% to 43,561.18 while the NASDAQ rose 2.23% to 18,849.87. The S&amp;P 500 also rose, gaining, 1.95% to 5,895.66.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/11/41774936/how-to-earn-500-a-month-from-qualcomm-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Qualcomm Stock Ahead Of Q4 Earnings</a>
Leading and Lagging Sectors Financial shares surged by 5.3% on Tuesday.
In trading on Tuesday, real estate shares fell by 3.2%.
Top Headline
Shares of CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) jumped more than 10% on Wednesday after the company reported third-quarter results.
The company reported third-quarter sales of $95.43 billion, beating the consensus of $92.75 billion. Total revenues increased 6.3%, primarily driven by growth in the Health Care Benefits and Pharmacy &amp; Consumer Wellness segments, partially offset by a decline in the Health Services segment.
Adjusted EPS of $1.09 (inline with preliminary guidance of $1.05-$1.10) decreased from $2.21 in the prior year, missing the consensus of $1.53.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Cytek Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTKB#NASDAQ">CTKB</a>) shares shot up 31% to $7.14 following upbeat quarterly results.</li>
<li>Shares of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) got a boost, surging 100% to $8.41 after the company announced the issuance of a U.S. patent covering an IL-18 variant into two novel immunotherapeutic drug candidates.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) shares were also up, gaining 24% to $7.15 following strong quarterly results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) shares dropped 42% to $4.12. Shares of solar stocks traded lower following Donald Trump&#8217;s presidential election victory.</li>
<li>Shares of Zoomcar Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) were down 39% to $8.05 after the company announced the pricing of $9.15 million private placement.</li>
<li>PACS Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) was down, falling 38% to $18.30 after the company announced postponement of third-quarter results and disclosure on civil investigative demands from the federal government.</li>
</ul>
Commodities In commodity news, oil traded up 0.8% to $72.53 while gold traded down 2.4% at $2,683.70.
Silver traded down 3.9% to $31.505 on Wednesday, while copper fell 4.5% to $4.2755.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.61%, Germany's DAX dipped 1.23% and France's CAC 40 fell 0.85%. Spain's IBEX 35 Index fell 3.14%, while London's FTSE 100 fell 0.08%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 2.61%, Hong Kong's Hang Seng Index falling 2.23%, China's Shanghai Composite Index falling 0.09% and India's BSE Sensex gaining 1.13%.
Economics
<ul>
<li>U.S. mortgage applications fell by 10.8% from the previous week in the week ended Nov. 1.</li>
<li>U.S. crude oil inventories increased by 2.149 million barrels in the week ended Nov. 1, compared to market estimates of a 1.8 million gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41773566/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yie">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields</a></li>
</ul>

Earnings

Equities

News

Eurozone

Commodities

Trading Ideas

CTKB

NOVA

PACS

SONN

TMCI

ZCAR

Gold Down Over 2%; CVS Health Shares Jump After Q3 Results

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) with a Buy and lowers the price target from $14 to $13.

Price Target

Analyst Ratings

AHCO

Canaccord Genuity Maintains Buy on AdaptHealth, Lowers Price Target to $13

Roth MKM analyst Matt Koranda reiterates Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) with a Buy and raises the price target from $29 to $35.

Reiteration

RVLV

Roth MKM Reiterates Buy on Revolve Gr, Raises Price Target to $35

TD Cowen analyst Phil Nadeau maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and raises the price target from $55 to $65.

RYTM

TD Cowen Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $65

WIIM

CDXC

ChromaDex shares are trading higher after Roth MKM maintained a Buy rating on the stock and raised its price target from $6 to $8.

The <a href="https://www.benzinga.com/personal-finance/24/10/41438273/can-you-guess-how-much-money-the-fat-fire-movement-says-you-need-to-retire-early-heres-a-hint-it">Financial Independence Retire Early (FIRE) movement</a> has captured attention across generations. It promises a life where financial independence allows you to retire early and focus on what you love. But not everyone is a fan. Financial expert Suze Orman has been famously critical of FIRE, labeling it dangerous for those without substantial wealth.
Don't Miss:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li><a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a></li>
</ul>
The FIRE movement is rooted in two main ideas: extreme saving and early retirement. By saving 50% or more of their income, followers of FIRE aim to accumulate a large retirement fund to live off investment returns, <a href="https://www.benzinga.com/personal-finance/24/08/40491347/47-year-old-unmotivated-multimillionaire-doctor-asks-dave-ramsey-retire-now-or-work-13-more-year">often before age 40</a>. While some adhere to "lean FIRE," maintaining a modest lifestyle with a smaller retirement fund, others pursue "fat FIRE," accumulating more to enjoy a comfortable lifestyle. The concept has gained significant traction, especially among millennials seeking alternatives to traditional career paths.
However, orman believes that FIRE oversimplifies the financial risks involved. In a 2018 interview on the Afford Anything podcast, she warned that even a seemingly substantial nest egg, like $2 million, might not be enough.&nbsp;
Trending: Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a>
"$2 million is nothing. It's nothing. It's pennies in today's world, to tell you the truth," she stated, expressing her concern that even millions could fall short in the face of life's uncertainties. Orman explained, "If a catastrophe happens … what are you going to do? You are going to burn up alive." For her, retirement requires far more planning than what many anticipate.&nbsp;
Orman's perspective is deeply rooted in the belief that financial independence requires a far larger cushion than most people realize. She even made a clear distinction between <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">average savers and the ultra-wealthy</a>. "If you have $20 [million], $40 [million], $50 [million] or $100 million, be like me, okay," Orman said. "If you have that kind of money … and want to retire, fine." But for the vast majority, she warns, retiring without that level of wealth is risky and could lead to financial disaster. Her message was simple: early retirement might not be safe unless you&#8217;re extraordinarily wealthy.
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
Orman's core criticism revolves around FIRE's approach to risk. She points out that unexpected expenses – like major health issues or long-term care – can devastate savings, especially for those who retire decades early. Orman illustrated the potential costs by suggesting that supporting a disabled family member could easily require $250,000 a year. Coupled with living expenses, she argues that maintaining a safe, sustainable retirement could require as much as $10 million in savings to ensure a comfortable life through any storms that might come.
With inflation steadily increasing, her projections from 2018 seem even more relevant now. Living costs, health care expenses and potential tax hikes have all risen, making financial independence harder to achieve than just a few years ago.
See Also: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Ultimately Orman advises that the risk of retiring early outweighs the reward if you're not <a href="https://www.benzinga.com/personal-finance/24/10/41125098/suze-orman-says-the-personal-finance-of-americans-is-really-really-bad-even-though-the-stock-mar">financially equipped for unforeseen hardships</a>. "If you don't have at least $5 million or $10 million, don't retire early," she emphasized. In her view, early retirement might work for those with vast resources – people who, like herself, have tens of millions to safeguard against all possibilities – but for everyone else, it's a path that could lead to financial ruin rather than freedom.
So, is FIRE worth pursuing? It depends on your risk tolerance, lifestyle goals and financial resilience.&nbsp;
The <a href="https://www.benzinga.com/personal-finance/24/09/40964924/most-people-expect-to-retire-at-67-but-56-retire-sooner-can-you-guess-the-actual-average-retirem">average retirement age</a> is 62, but Orman strongly advocates working longer and <a href="https://www.benzinga.com/personal-finance/24/05/39064579/suze-orman-says-70-is-the-new-retirement-age-but-is-she-right">delaying Social Security until 70</a> to maximize those benefits. <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">Consulting with a financial advisor could be one of the smartest moves</a> for anyone eyeing an early exit from work. An advisor can help you stress-test your retirement plan, look at real-life scenarios and ensure you're prepared for whatever may come.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>According to Vanguard&#8217;s Advisor&#8217;s Alpha Study, working with a financial advisor can result in approximately 3% higher net returns annually,<a href="https://www.benzinga.com/money/3-percent-advantage-financial-advisor"> here are the benefits of partnering with a financial advisor and how to find the right one near you in minutes.</a></li>
</ul>

Personal Finance

Suze Orman Says If You're Rich 'Like Her' Then You Can Retire Early – But If You Only Have $2 Million Saved: 'You'll Burn Up Alive'

TD Cowen analyst Dan Brennan maintains Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) with a Hold and lowers the price target from $72 to $70.

BRKR

TD Cowen Maintains Hold on Bruker, Lowers Price Target to $70

Roth MKM analyst Chip Moore maintains Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) with a Buy and lowers the price target from $84 to $70.

Roth MKM Maintains Buy on Hyster Yale, Lowers Price Target to $70

Honda Motor Company, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) shares are trading lower on Wednesday following a decline in the first-half profit and reduced <a href="https://global.honda/en/investors/library/documents/main/00/teaserItems3/00/linkList/00/link/FYE202503_2Q_financial_presentation_e_1.pdf" target="_blank" rel="noreferrer noopener">annual </a>profit forecast.
The company reported the first half of FY24 revenue growth of 12.4% year over year 10.798 trillion yen ($69.9 billion), while profits declined 19.7% to 494.6 billion Yen ($3.20 billion).
Automobile consolidated unit sales rose by 64,000 units, driven by strong ICE/HEV sales and the full-scale launch of <a target="_blank" href="https://global.honda/en/investors/library/documents/main/00/teaserItems3/00/linkList/03/link/FYE202503_2Q_financial_presentation_script_e.pdf" rel="noreferrer noopener">EVs </a>in North America.
However, group unit sales fell by 155,000 units, primarily due to lower sales in China.
In the motorcycle business, global sales remained robust, reaching a cumulative total of 10 million units by the end of the second quarter.
Operating profit rose 6.6% to 742.6 billion yen, with a margin of 6.9% (vs<a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">. 7.2% in the first half of FY23)</a>.
Additionally, a resolution was made at the company&#8217;s board meeting to repurchase company shares, up to 100 billion yen.
Outlook: For FY25, the company reduced profit for the year attributable to owners of the parent by 50 billion yen to 950 billion yen due to lower equity method profit from reduced sales in China and decreased profit in <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">Honda&#8217;s affiliates in Japan</a>.
On the other hand, the company raised the sales revenue forecast by 700 billion yen to 21.000 trillion yen.
Meanwhile, Honda reiterated its FY25 operating profit forecast at 1.420 trillion yen.
Price Action: HMC shares are down 9.72% at $27.36 at the last check Wednesday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41699452/hondas-pickup-beats-tesla-cybertruck-as-most-american-made-truck" target="_blank" rel="noreferrer noopener">Honda&#8217;s Pickup Beats Tesla Cybertruck As Most American Made Truck</a></li>
</ul>

Large Cap

Movers

Honda Reports 19.7% Profit Decline in H1, Lowers Annual Profit Forecast Amid China Sales Slump

TD Cowen analyst Yaron Werber maintains BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) with a Hold and lowers the price target from $132 to $122.

BNTX

TD Cowen Maintains Hold on BioNTech, Lowers Price Target to $122

Canaccord Genuity analyst Kyle Mikson maintains Exact Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) with a Buy and lowers the price target from $95 to $75.

EXAS

Canaccord Genuity Maintains Buy on Exact Sciences, Lowers Price Target to $75

Donald Trump has been elected as the 47th president of the U.S., and the future of <a href="https://www.benzinga.com/electric-vehicles">the electric vehicle (EV) industry</a> is uncertain. 
Here's a look at how the president-elect&#8217;s policy changes could affect<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41755274/trump-win-could-hinder-tech-ev-sector-growth-slow-the-pace-of-ai-revolution-analyst"> EV makers in the US. </a>
Trump's EV Views: Trump, who <a href="https://www.benzinga.com/markets/equities/24/10/41562048/leonardo-dicaprio-backs-harris-says-trump-continues-to-deny-the-facts-on-climate">has denied climate change</a>, as largely condemned EVs. He claims they will cost autoworkers' jobs as factories make the shift to electric vehicles. He has also said EVs are<a href="https://www.benzinga.com/news/24/07/39854007/trump-says-he-will-end-the-electric-vehicle-mandate-on-day-one-days-after-tesla-ceo-elon-musks-endor"> being forced </a>on consumers through unfair regulations. 
"I will end the electric vehicle mandate on day one, thereby saving the auto industry from complete obliteration which is happening right now and saving US customers thousands and thousands of dollars per car," Trump said in a speech at the Republican National Convention in July.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/11/41754367/china-escalates-trade-dispute-lodges-complaint-with-wto-over-european-ev-tariffs">China Escalates Trade Dispute, Lodges Complaint With WTO Over European EV Tariffs</a>
Trump has also said he plans <a href="https://www.benzinga.com/news/24/07/39854007/trump-says-he-will-end-the-electric-vehicle-mandate-on-day-one-days-after-tesla-ceo-elon-musks-endor">to eliminate</a> many vehicle emissions standards under the Environmental Protection Agency as well as many EV incentives included in the Biden administration's Inflation Reduction Act (IRA).
Analysts Weigh In: Wedbush analysts, including Dan Ives, see <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41755274/trump-win-could-hinder-tech-ev-sector-growth-slow-the-pace-of-ai-revolution-analyst">trouble ahead</a> for the EV industry.&nbsp;
&#8220;We believe a Trump presidency would be an overall negative for the EV industry as likely the EV rebates/tax incentives get pulled, however for Tesla we see this as a potential positive with some caveats,&#8221; the Wedbush analysts wrote.&nbsp;
The analysts pointed to Tesla, Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) profitability, along with the company's size and scale, as advantages over its competitors who may struggle after losing rebates and tax incentives. Wedbush also sees Tesla benefiting from higher import fees on Chinese EVs under a Trump administration. 
&#8220;Higher China tariffs that would continue to push away cheaper EV players (BYD, Nio, etc.) from flooding the US market over the coming years,&#8221; Wedbush wrote.&nbsp;
Tesla CEO Elon Musk, who campaigned heavily <a href="https://www.benzinga.com/news/24/11/41766808/mark-cuban-congratulates-trump-musk-before-the-election-is-called-says-they-won-fair-and-square">for the GOP leader</a>, acknowledged that a Trump presidency would likely mean the end of EV subsidies and tax credits during Tesla's second-quarter earnings call. 
The impact would be slight for Tesla and devastating for its competitors, Musk said.
"But long term probably actually helps Tesla, would be my guess, yes," Musk said.&nbsp;
The Big 3: Legacy automakers, General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) are struggling as they transition from traditional combustion engines to EVs. 
The Big 3 automakers have recently announced they will delay investments and other plans related to the production of EVs amid <a href="https://www.benzinga.com/news/24/11/41737069/ford-ev-sales-drop-over-8-in-october-as-demand-for-f-150-lightning-slows-down">waning demand </a>from consumers. 
What's Next: It remains to be seen what measures will be repealed under a Trump administration and how each automaker will be affected. However, investors seem to agree with Tesla analysts that Trump's second term is a positive catalyst for the EV giant. Tesla shares are soaring 12.8% higher at $283.49 at the time of publication Wednesday, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>.&nbsp;
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">Trump&#8217;s Big Tech Policies: What GOP Victory Means For Apple, Google, Microsoft</a></li>
</ul>
Image: Shutterstock

Politics

STLA

TSLA

What Does Trump's Victory Mean For EV Giant Tesla And The Big 3 Automakers?

Roth MKM analyst Bill Kirk maintains Grocery Outlet Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) with a Neutral and lowers the price target from $20 to $16.

Roth MKM Maintains Neutral on Grocery Outlet Holding, Lowers Price Target to $16

Roth MKM analyst Jason Wittes reiterates Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) with a Buy and maintains $100 price target.

GMED

Roth MKM Reiterates Buy on Globus Medical, Maintains $100 Price Target

For Kevin O&#8217;Leary, the business world is black and white: you either succeed or fail. "Business is binary. There are winners and losers. You either make money or you don't," he says.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Business is binary. There are winners and losers. You either make money or you lose it. If you want to succeed in business you have to work 25hrs a day because there's someone across the world who will kick your a&#x2A;s if you don't. <a href="https://t.co/mRURSOPoz8">pic.twitter.com/mRURSOPoz8</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1853432280565330223?ref_src=twsrc%5Etfw">November 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
O&#8217;Leary, famously known as &#8220;Mr. Wonderful&#8221; on Shark Tank, loves sharing his formula for success, especially with young entrepreneurs. His advice is direct: if you&#8217;re in your 20s and trying to build a business, forget about having a work-life balance. The competition is just too intense.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
&#8220;You're competing with people in Mumbai or Shanghai who are <a href="https://www.benzinga.com/startups/24/10/41231722/kevin-oleary-says-theres-no-worklife-balance-for-new-entrepreneurs-as-guys-in-mumbai-or-shanghai-wor">willing to work 24 hours a day</a>, eight days a week,&#8221; O&#8217;Leary once said. In his view, you&#8217;re at risk of being left behind unless you&#8217;re ready to put in those kinds of hours. He even goes so far as to say that to be successful, you need to work relentlessly or as he puts it, &#8220;25 hours a day.&#8221;&nbsp;
Working around the clock sounds extreme to most people, but O&#8217;Leary knows the importance of laying a strong foundation in the early stages of your career. When you're young, you have the time and energy to make sacrifices because &#8220;In your 20s, you can afford the time, the focus and all the stress that comes with building something from the ground up. You should start thinking about taking some time off only after establishing that foundation.&#8221;
Trending: With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today.</a>
O&#8217;Leary knows firsthand how frustrating it can be to slow down. After selling The Learning Company, he was <a href="https://www.benzinga.com/startups/24/09/40776473/it-was-boring-kevin-oleary-explored-every-beach-on-earth-after-he-first-got-rich-but-the-highs-and-l?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=41231722">tied up in a noncompete agreement</a> that kept him out of the software industry for three years. What many might see as a well-earned break was stifling for O&#8217;Leary, who said he felt &#8220;stale&#8221; without the ability to work. He quickly understood that his feeling of purpose depended on his ability to continue building businesses.
This relentless pursuit of success is also reflected in his approach to investing. O&#8217;Leary has one rule regarding money: always invest in information. &#8220;If you make decisions without relevant information, I guarantee you, you will lose money 100% of the time,&#8221; he said.&nbsp;
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Each day, <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/01/30554489/kevin-oleary-reveals-his-secret-to-success-what-he-does-every-day-to-avoid-losing-money-">O&#8217;Leary starts his mornings early</a>, dedicating an hour to consuming news from various sources – early broadcasts from Europe and Asia or academic and financial research.
For O&#8217;Leary, the lesson is straightforward: Sacrifice is necessary for success. To succeed as an entrepreneur, you must be prepared to work harder and longer hours than your competitors, stay informed and persevere.
Read Next:
<ul>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's an opportunity to invest at $1,000 for only $0.50/share today.</a></li>
</ul>

Startups

Kevin O'Leary Claims 'You Have To Work 25 Hours A Day.' For Him, Business Is Simple: 'You Either Make Money Or You Don't'

CRCT

Cricut shares are trading lower after the company cut its price target on the stock from $6.5 to $5.75.

Roth MKM analyst Sean McGowan maintains ChromaDex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) with a Buy and raises the price target from $6 to $8.

Roth MKM Maintains Buy on ChromaDex, Raises Price Target to $8

Dine Brands Global shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$250.00</td>
<td>$107.0K</td>
<td>4.1K</td>
<td>12.4K</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$72.50</td>
<td>$98.4K</td>
<td>3.7K</td>
<td>7.4K</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$180.00</td>
<td>$1.4 million</td>
<td>654</td>
<td>5.5K</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$135.00</td>
<td>$70.0K</td>
<td>10</td>
<td>3.2K</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$29.00</td>
<td>$29.9K</td>
<td>233</td>
<td>2.1K</td>
</tr>
<tr>
<td>KKR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$100.00</td>
<td>$131.5K</td>
<td>3.4K</td>
<td>260</td>
</tr>
<tr>
<td>BLK</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1000.00</td>
<td>$407.5K</td>
<td>4</td>
<td>100</td>
</tr>
<tr>
<td>RJF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$170.00</td>
<td>$40.0K</td>
<td>16</td>
<td>100</td>
</tr>
<tr>
<td>TFC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$35.00</td>
<td>$94.5K</td>
<td>2.0K</td>
<td>80</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$500.00</td>
<td>$34.7K</td>
<td>1.6K</td>
<td>31</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on November 8, 2024. Parties traded 214 contract(s) at a $250.00 strike. This particular call needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $107.0K, with a price of $500.0 per contract. There were 4138 open contracts at this strike prior to today, and today 12429 contract(s) were bought and sold. 
• Regarding C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we observe a call option sweep with bullish sentiment. It expires in 44 day(s) on December 20, 2024. Parties traded 639 contract(s) at a $72.50 strike. This particular call needed to be split into 28 different trades to become filled. The total cost received by the writing party (or parties) was $98.4K, with a price of $154.0 per contract. There were 3795 open contracts at this strike prior to today, and today 7475 contract(s) were bought and sold. 
• For BX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), we notice a call option sweep that happens to be bullish, expiring in 135 day(s) on March 21, 2025. This event was a transfer of 1240 contract(s) at a $180.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $1.4 million, with a price of $1150.0 per contract. There were 654 open contracts at this strike prior to today, and today 5551 contract(s) were bought and sold. 
• For MS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), we notice a put option sweep that happens to be bullish, expiring in 72 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $135.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $70.0K, with a price of $700.0 per contract. There were 10 open contracts at this strike prior to today, and today 3256 contract(s) were bought and sold. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a put option sweep with bearish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 113 contract(s) at a $29.00 strike. This particular put needed to be split into 21 different trades to become filled. The total cost received by the writing party (or parties) was $29.9K, with a price of $265.0 per contract. There were 233 open contracts at this strike prior to today, and today 2178 contract(s) were bought and sold. 
• For KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), we notice a call option sweep that happens to be bearish, expiring in 317 day(s) on September 19, 2025. This event was a transfer of 23 contract(s) at a $100.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $131.5K, with a price of $5720.0 per contract. There were 3464 open contracts at this strike prior to today, and today 260 contract(s) were bought and sold. 
• Regarding BLK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), we observe a put option trade with bearish sentiment. It expires in 436 day(s) on January 16, 2026. Parties traded 50 contract(s) at a $1000.00 strike. The total cost received by the writing party (or parties) was $407.5K, with a price of $8150.0 per contract. There were 4 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• Regarding RJF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>), we observe a call option trade with bearish sentiment. It expires in 191 day(s) on May 16, 2025. Parties traded 50 contract(s) at a $170.00 strike. The total cost received by the writing party (or parties) was $40.0K, with a price of $800.0 per contract. There were 16 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• For TFC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>), we notice a call option trade that happens to be bullish, expiring in 226 day(s) on June 20, 2025. This event was a transfer of 80 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $94.5K, with a price of $1182.0 per contract. There were 2070 open contracts at this strike prior to today, and today 80 contract(s) were bought and sold. 
• Regarding MA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), we observe a call option trade with bearish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 11 contract(s) at a $500.00 strike. The total cost received by the writing party (or parties) was $34.7K, with a price of $3162.0 per contract. There were 1606 open contracts at this strike prior to today, and today 31 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares

ニュース

最新ニュース Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (ARCA:DRIP)

ニュース

パートナーシップ

ベンジンガ・グローバル